Trading Ideas

F.N.B. Corporation (NYSE:FNB) defied analyst predictions to release its quarterly results, which were ahead of market… …read more […]

A Fisker IPO is coming to the market. The company recently announced it’s going public via acquisition, the latest trend in the IPO market. Now, investors want to know when to expect Fisker stock.
But is Fisker a good investment opportunity? Here’s what we know…
Fisker IPO: The Business

Henrik Fisker is an auto-designer. He designed the BMW Z8 and Aston Martin DB9. Fisker founded Fisker Automotive in 2007. It produced one of the world’s first luxury plug-in hybrid elective vehicles (EV), the Fisker Karma. The Karma debuted in the 2008 North American International Auto Show. It was delivered in 2011. However, in …read more […]

Caribbean nations like St. Lucia, Antigua, and many others are selling discounted citizenships in an effort to help their economies recover from lost tourism spending amid COVID-19. …read more […]

Most readers would already be aware that Quidel’s (NASDAQ:QDEL) stock increased significantly by 148% over the past… …read more […]

A week ago, Abbott Laboratories (NYSE:ABT) came out with a strong set of second-quarter numbers that could potentially… …read more […]

(Bloomberg) — When Joe Biden released his climate plan last week, the Democratic candidate for president emphasized one overarching goal—and it wasn’t the reduction of greenhouse gases. Instead, he unequivocally linked broad climate action to employment.“When Donald Trump thinks about climate change, the only word he can muster is ‘hoax,’” Biden said in a speech unveiling the plan. “When I think about climate change, the word I think of is ‘jobs.’” His proposal aims to create 1 million openings in the auto sector, in part by investing in electric vehicle charging, plus another 1 million positions retrofitting homes for …read more […]

…read more […]

(Bloomberg) — The Mt Arthur coal mine in Australia is one of the world’s best. It’s got plenty of reserves and the low-cost supplies produced there are easily shipped to Southeast Asia, where there’s insatiable appetite for the fuel.Yet owner BHP Group has a problem: It’s struggling to find a buyer willing to pay the right price.The world’s biggest mining company’s unsuccessful effort over the past year to offload the asset highlights the predicament producers are in. To bow to mounting investor pressure to exit the most polluting fuel, BHP may need to sell a profitable mine for much less …read more […]

In a letter to Vice President Mike Pence and Secretary of Health and Human Services (HHS) Alex Azar, the Infectious Diseases Society of America (IDSA) expressed concern that developed countries are relying on a single manufacturer for the only antiviral so far shown to be effective against COVID-19, the disease caused by the coronavirus. Remdesivir is made by Gilead Sciences Inc, which has committed to supplying 500,000 treatment courses of the drug to HHS for distribution to U.S. hospitals in July, August and September. …read more […]

Any risk-tolerant investor will be hard pressed to find a penny stock that better embodies the description than Greek oil tanker operator Top Ships (TOPS). Shares are going for $0.11 apiece, after a multi-year ride to the bottom. In 2020 alone, the stock is down by 86% so far. Adding insult to injury, the only analyst on Wall Street keeping a close eye on the vessel operator recently downgraded his rating.Maxim analyst Tate Sullivan dropped his rating from Buy to Hold and also removed his price target, citing “potential for delays at shipyards delivering five new ships to TOPS in …read more […]

Stocks go up, stocks go down, you can’t explain that…Or maybe you can, if the stock happen to be a biotech that just flunked a clinical trial. Which leads us nicely to Celsion Corporation (CLSN). Or not so nicely if you happen to be an investor.Shares cratered by a dispiriting 68% this week after the company announced that the independent Data Monitoring Committee (DMC) recommended it prematurely bring to an end its Phase 3 OPTIMA study evaluating ThermoDox in patients with primary liver cancer.Based on an interim safety and efficacy analysis, the DMC concluded the study was unlikely to achieve …read more […]

The viral outbreak might be having a ruinous effect on a host of industries, but it is no secret some have thrived in these conditions. Hardly any more so e-commerce platform Shopify (SHOP). Shares are up by 133% year-to date, although to be fair, it’s not as if Shopify needed a helping hand before the pandemic struck. Overall, since debuting on the New York Stock Exchange for $28 a share in May 2015, the stock is up by 3,320% and Shopify has positioned itself as one of the 21st century’s tech giants.But there’s room for another slight uptick from here, …read more […]

After a solid start to 2020, semiconductor companies got rocked in March at the onset of the US coronavirus outbreak, posting both year-over-year and quarter-over-quarter losses during Q1. Despite disappointing financials, many of these companies’ stocks have rebounded and even surpassed pre-pandemic highs. Household names including Intel (INTC), AMD (AMD), Qualcomm (QCOM), and more have all rebounded by more than 30% since mid-March lows.For tech investors, determining short-term swings of these corporations will be difficult. While major market indexes are performing up to par, ambiguity concerning COVID-19 has once again ramped up, and consumer purchasing sentiment is also relatively unknown.To …read more […]

(Bloomberg Opinion) — China’s cosmetic brands may finally be ready to face down their foreign rivals, thanks to the Covid outbreak and a wave of patriotic buying. The rising popularity of domestic makeup products is an example of how the pandemic upheaval and geopolitical tensions are creating unexpected winners and losers.Shares of Proya Cosmetics Co., Guangdong Marubi Biotechnology Co. and Shanghai Jahwa United Co. have soared this year, outpacing the gain in Shanghai’s benchmark index. Meanwhile, mid-range cosmetics makers such as Japan’s Shiseido Co. and South Korea’s Amorepacific Corp. — those most vulnerable to the rise of Chinese competition — …read more […]

NIO’s stock price reflects “over-optimism”, says Goldman Sachs analyst Fei Fang. …read more […]